Not applicableStudy completedNCT04748185
What this trial is testing
Immunogenicity and Safety of Commercially Available Vaccines Against SARS-CoV-2 (COVID-19) in Patients With Hematologic Malignancies
Who this might be right for
Monoclonal B-Cell LymphocytosisChronic Lymphocytic Leukemia/Small Lymphocytic LymphomaB-cell Non Hodgkin Lymphoma+1 more
Mayo Clinic 358